Background: An ongoing outbreak of pneumonia caused by a novel coronavirus [severe acute respiratory syndrome coronavirus (SARS-CoV)-2], named COVID-19, hit a major city of China, Wuhan in December 2019 and subsequently spread to other provinces/regions of China and overseas. Several studies have been done to estimate the basic reproduction number in the early phase of this outbreak, yet there are no reliable estimates of case fatality rate (CFR) for COVID-19 to date.
Methods: In this study, we used a purely data-driven statistical method to estimate the CFR in the early phase of the COVID-19 outbreak. Daily numbers of laboratory-confirmed COVID-19 cases and deaths were collected from January 10 to February 3, 2020 and divided into three clusters: Wuhan city, other cities of Hubei province, and other provinces of mainland China. Simple linear regression model was applied to estimate the CFR from each cluster.
Results: We estimated that CFR during the first weeks of the epidemic ranges from 0.15% (95% CI: 0.12-0.18%) in mainland China excluding Hubei through 1.41% (95% CI: 1.38-1.45%) in Hubei province excluding the city of Wuhan to 5.25% (95% CI: 4.98-5.51%) in Wuhan.
Conclusions: Our early estimates suggest that the CFR of COVID-19 is lower than the previous coronavirus epidemics caused by SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV).
Keywords: 2019 novel coronavirus; COVID-19; case fatality rate (CFR); severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
2020 Annals of Translational Medicine. All rights reserved.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).Clin Exp Pediatr. 2020 Apr;63(4):119-124. doi: 10.3345/cep.2020.00493. Epub 2020 Apr 2. Clin Exp Pediatr. 2020. PMID: 32252141 Free PMC article.
Features, Evaluation and Treatment Coronavirus (COVID-19).2020 Apr 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–. StatPearls. 2020 Jan–. PMID: 32150360 Free Books & Documents. Review.
Modeling the epidemic dynamics and control of COVID-19 outbreak in China.Quant Biol. 2020 Mar 11:1-9. doi: 10.1007/s40484-020-0199-0. Online ahead of print. Quant Biol. 2020. PMID: 32219006 Free PMC article.
Estimating Risk for Death from Coronavirus Disease, China, January-February 2020.Emerg Infect Dis. 2020 Jun;26(6):1251-1256. doi: 10.3201/eid2606.200233. Epub 2020 Jun 17. Emerg Infect Dis. 2020. PMID: 32168464
Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China.J Clin Med. 2020 Feb 20;9(2):575. doi: 10.3390/jcm9020575. J Clin Med. 2020. PMID: 32093211 Free PMC article. Review.
Cited by 6 articles
Rare and extreme events: the case of COVID-19 pandemic.Nonlinear Dyn. 2020 May 16:1-20. doi: 10.1007/s11071-020-05680-w. Online ahead of print. Nonlinear Dyn. 2020. PMID: 32427206 Free PMC article.
Age-Dependent Risks of Incidence and Mortality of COVID-19 in Hubei Province and Other Parts of China.Front Med (Lausanne). 2020 Apr 30;7:190. doi: 10.3389/fmed.2020.00190. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32426363 Free PMC article.
The challenges in colorectal cancer management during COVID-19 epidemic.Ann Transl Med. 2020 Apr;8(7):498. doi: 10.21037/atm.2020.03.158. Ann Transl Med. 2020. PMID: 32395542 Free PMC article. Review.
Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view.New Microbes New Infect. 2020 Mar 31;35:100672. doi: 10.1016/j.nmni.2020.100672. eCollection 2020 May. New Microbes New Infect. 2020. PMID: 32322400 Free PMC article. Review.
Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status.Infect Genet Evol. 2020 Apr 19;83:104327. doi: 10.1016/j.meegid.2020.104327. Online ahead of print. Infect Genet Evol. 2020. PMID: 32320825 Free PMC article. Review.